|
 |
|
| |
|
Newsletter Sponsor
|
|
Process Understanding Central to Successful Drug Synthesis
James Springer and Robert Hughes – senior R&D staff from Albemarle FCS – discuss how a high level of process understanding is required with today’s complex APIs to achieve the necessary robust, high-yielding and cost-effective synthetic routes.
For 40+ years, Albemarle FCS has been delivering a reliable supply of RSMs, intermediates and APIs. Its long-tenured teams bring continuity and experience, with the ability to efficiently scale up from RSMs to complex APIs between integrated US facilities.
 |
|
|
|
|
|
|
|
|
|
 |
Featured Articles |
 |
|
| |
|
|
|
An Interview with... Alcami
If current trends hold, it is expected that new parenteral products will be increasingly complex, requiring nonstandard manufacturing technologies subjected to higher standards of regulatory scrutiny ...
read more » |
 |
|
|
 |
| |
|
|
Featured Video |
|
|
| |
|
|
|
Watch Video: CordenPharma Colorado Tour
CordenPharma is a full-service Contract Development & Manufacturing Organization (CDMO) organized under five Technology Platforms – Peptides, Oligonucleotides, Lipids, & Carbohydrates – Injectables - ...
read more » |
|
|
|
|
|
|
 |
| |
|
|
|
|
|
Events
|
|
|
|
| |
|
|
|
BIO One-on-One Partnering™
Philadelphia, PA – 06/03/2019
Join us at BIO 2019, June 3-6, for the world’s largest biotechnology partnering event of the year! BIO One-on-One Partnering™ is the most efficient ...
event details » |
|
|
|
|
|
 |
|
|
